Correlation Between BioInvent International and Egetis Therapeutics

Can any of the company-specific risk be diversified away by investing in both BioInvent International and Egetis Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining BioInvent International and Egetis Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between BioInvent International AB and Egetis Therapeutics AB, you can compare the effects of market volatilities on BioInvent International and Egetis Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in BioInvent International with a short position of Egetis Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of BioInvent International and Egetis Therapeutics.

Diversification Opportunities for BioInvent International and Egetis Therapeutics

0.13

Correlation Coefficient

BioInvent International  Egetis Therapeutics

Average diversification

The 3 months correlation between BioInvent and Egetis is 0.13. Overlapping area represents the amount of risk that can be diversified away by holding BioInvent International AB and Egetis Therapeutics AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Egetis Therapeutics and BioInvent International is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on BioInvent International AB are associated (or correlated) with Egetis Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Egetis Therapeutics has no effect on the direction of BioInvent International i.e., BioInvent International and Egetis Therapeutics go up and down completely randomly.

Pair Corralation between BioInvent International and Egetis Therapeutics

Assuming the 90 days trading horizon BioInvent International is expected to generate 1.38 times less return on investment than Egetis Therapeutics. In addition to that, BioInvent International is 1.03 times more volatile than Egetis Therapeutics AB. It trades about 0.13 of its total potential returns per unit of risk. Egetis Therapeutics AB is currently generating about 0.18 per unit of volatility. If you would invest  349.00  in Egetis Therapeutics AB on April 21, 2025 and sell it today you would earn a total of  195.00  from holding Egetis Therapeutics AB or generate 55.87% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

BioInvent International AB  vs.  Egetis Therapeutics AB

BioInvent International

Risk-Adjusted Performance

OK

Compared to the overall equity markets, risk-adjusted returns on investments in BioInvent International AB are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain basic indicators, BioInvent International unveiled solid returns over the last few months and may actually be approaching a breakup point.

Egetis Therapeutics

Risk-Adjusted Performance

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Egetis Therapeutics AB are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak basic indicators, Egetis Therapeutics unveiled solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with BioInvent International and Egetis Therapeutics

The main advantage of trading using opposite BioInvent International and Egetis Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if BioInvent International position performs unexpectedly, Egetis Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Egetis Therapeutics will offset losses from the drop in Egetis Therapeutics' long position.

The idea behind BioInvent International AB and Egetis Therapeutics AB pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.